Annual Total Long Term Liabilities
$104.77 M
+$50.77 M+94.01%
31 December 2023
Summary:
Lexicon Pharmaceuticals annual total long term liabilities is currently $104.77 million, with the most recent change of +$50.77 million (+94.01%) on 31 December 2023. During the last 3 years, it has risen by +$104.16 million (+17047.79%). LXRX annual total long term liabilities is now -61.73% below its all-time high of $273.79 million, reached on 31 December 2018.LXRX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$106.56 M
+$1.06 M+1.01%
30 September 2024
Summary:
Lexicon Pharmaceuticals quarterly total long term liabilities is currently $106.56 million, with the most recent change of +$1.06 million (+1.01%) on 30 September 2024. Over the past year, it has increased by +$1.86 million (+1.77%). LXRX quarterly long term liabilities is now -61.39% below its all-time high of $275.98 million, reached on 31 March 2019.LXRX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LXRX Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +94.0% | +1.8% |
| 3 y3 years | +10000.0% | +7095.5% |
| 5 y5 years | -61.7% | -54.7% |
LXRX Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | >+9999.0% | at high | +8855.0% |
| 5 y | 5 years | -61.7% | >+9999.0% | -54.8% | >+9999.0% |
| alltime | all time | -61.7% | >+9999.0% | -61.4% | >+9999.0% |
Lexicon Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $106.56 M(+1.0%) |
| June 2024 | - | $105.50 M(+0.5%) |
| Mar 2024 | - | $104.95 M(+0.2%) |
| Dec 2023 | $104.77 M(+94.0%) | $104.77 M(+0.1%) |
| Sept 2023 | - | $104.71 M(+0.4%) |
| June 2023 | - | $104.25 M(+92.0%) |
| Mar 2023 | - | $54.30 M(+0.5%) |
| Dec 2022 | $54.00 M(+4438.1%) | $54.00 M(+84.8%) |
| Sept 2022 | - | $29.22 M(+18.6%) |
| June 2022 | - | $24.63 M(+0.2%) |
| Mar 2022 | - | $24.57 M(+1965.1%) |
| Dec 2021 | $1.19 M(+94.8%) | $1.19 M(-19.6%) |
| Sept 2021 | - | $1.48 M(-8.8%) |
| June 2021 | - | $1.62 M(-5.5%) |
| Mar 2021 | - | $1.72 M(+181.2%) |
| Dec 2020 | $611.00 K(-99.7%) | $611.00 K(-95.1%) |
| Sept 2020 | - | $12.37 M(-94.8%) |
| June 2020 | - | $235.67 M(+0.1%) |
| Mar 2020 | - | $235.47 M(+0.1%) |
| Dec 2019 | $235.27 M(-14.1%) | $235.27 M(+0.1%) |
| Sept 2019 | - | $235.05 M(-14.7%) |
| June 2019 | - | $275.56 M(-0.2%) |
| Mar 2019 | - | $275.98 M(+0.8%) |
| Dec 2018 | $273.79 M(+4.2%) | $273.79 M(+1.0%) |
| Sept 2018 | - | $271.09 M(+5.6%) |
| June 2018 | - | $256.67 M(-1.4%) |
| Mar 2018 | - | $260.25 M(-1.0%) |
| Dec 2017 | $262.79 M(+71.1%) | $262.79 M(+114.7%) |
| Sept 2017 | - | $122.38 M(-1.3%) |
| June 2017 | - | $124.03 M(-0.5%) |
| Mar 2017 | - | $124.60 M(-18.9%) |
| Dec 2016 | $153.58 M(-36.8%) | $153.58 M(-5.0%) |
| Sept 2016 | - | $161.65 M(-23.0%) |
| June 2016 | - | $209.81 M(-11.3%) |
| Mar 2016 | - | $236.52 M(-2.7%) |
| Dec 2015 | $243.15 M(+70.8%) | $243.15 M(+72.0%) |
| Sept 2015 | - | $141.40 M(+0.3%) |
| June 2015 | - | $140.92 M(-0.2%) |
| Mar 2015 | - | $141.14 M(-0.9%) |
| Dec 2014 | $142.39 M(+68.1%) | $142.39 M(+117.6%) |
| Sept 2014 | - | $65.43 M(-23.5%) |
| June 2014 | - | $85.50 M(+0.4%) |
| Mar 2014 | - | $85.15 M(+0.5%) |
| Dec 2013 | $84.70 M(-2.4%) | $84.70 M(-6.0%) |
| Sept 2013 | - | $90.15 M(+33.7%) |
| June 2013 | - | $67.41 M(-23.1%) |
| Mar 2013 | - | $87.69 M(+1.0%) |
| Dec 2012 | $86.81 M | $86.81 M(+0.9%) |
| Sept 2012 | - | $86.03 M(-24.9%) |
| June 2012 | - | $114.61 M(+1.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $112.89 M(+1.2%) |
| Dec 2011 | $111.55 M(+2.3%) | $111.55 M(+1.0%) |
| Sept 2011 | - | $110.42 M(+1.8%) |
| June 2011 | - | $108.50 M(-1.0%) |
| Mar 2011 | - | $109.61 M(+0.5%) |
| Dec 2010 | $109.08 M(+151.9%) | $109.08 M(+22.5%) |
| Sept 2010 | - | $89.07 M(+108.7%) |
| June 2010 | - | $42.67 M(-0.7%) |
| Mar 2010 | - | $42.99 M(-0.7%) |
| Dec 2009 | $43.31 M(-2.7%) | $43.31 M(-0.7%) |
| Sept 2009 | - | $43.62 M(-46.1%) |
| June 2009 | - | $80.87 M(+37.4%) |
| Mar 2009 | - | $58.88 M(+32.3%) |
| Dec 2008 | $44.51 M(-6.1%) | $44.51 M(-0.6%) |
| Sept 2008 | - | $44.76 M(-0.5%) |
| June 2008 | - | $44.99 M(-1.6%) |
| Mar 2008 | - | $45.73 M(-3.5%) |
| Dec 2007 | $47.38 M(-19.4%) | $47.38 M(-4.2%) |
| Sept 2007 | - | $49.48 M(-4.2%) |
| June 2007 | - | $51.62 M(-6.5%) |
| Mar 2007 | - | $55.20 M(-6.1%) |
| Dec 2006 | $58.80 M(-22.1%) | $58.80 M(-5.9%) |
| Sept 2006 | - | $62.48 M(-5.8%) |
| June 2006 | - | $66.33 M(-6.4%) |
| Mar 2006 | - | $70.88 M(-6.1%) |
| Dec 2005 | $75.45 M(+46.0%) | $75.45 M(-6.6%) |
| Sept 2005 | - | $80.79 M(+35.5%) |
| June 2005 | - | $59.61 M(+25.3%) |
| Mar 2005 | - | $47.56 M(-8.0%) |
| Dec 2004 | $51.68 M(-40.1%) | $51.68 M(-15.3%) |
| Sept 2004 | - | $61.01 M(+6.1%) |
| June 2004 | - | $57.52 M(-30.4%) |
| Mar 2004 | - | $82.63 M(-4.2%) |
| Dec 2003 | $86.22 M(+715.6%) | $86.22 M(+944.9%) |
| Sept 2003 | - | $8.25 M(-9.6%) |
| June 2003 | - | $9.13 M(-7.4%) |
| Mar 2003 | - | $9.86 M(-6.8%) |
| Dec 2002 | $10.57 M(+272.3%) | $10.57 M(+1857.6%) |
| Sept 2002 | - | $540.00 K(+68.8%) |
| June 2002 | - | $320.00 K(-79.7%) |
| Mar 2002 | - | $1.58 M(-44.4%) |
| Dec 2001 | $2.84 M(+54.8%) | $2.84 M(-25.5%) |
| Sept 2001 | - | $3.81 M(-23.8%) |
| June 2001 | - | $5.00 M(+216.6%) |
| Mar 2001 | - | $1.58 M(-13.9%) |
| Dec 2000 | $1.83 M(-48.7%) | $1.83 M(-17.0%) |
| Sept 2000 | - | $2.21 M(-8.7%) |
| June 2000 | - | $2.42 M(-26.8%) |
| Mar 2000 | - | $3.31 M |
| Dec 1999 | $3.58 M | - |
FAQ
- What is Lexicon Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Lexicon Pharmaceuticals?
- What is Lexicon Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Lexicon Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Lexicon Pharmaceuticals?
- What is Lexicon Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Lexicon Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of LXRX is $104.77 M
What is the all time high annual total long term liabilities for Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals all-time high annual total long term liabilities is $273.79 M
What is Lexicon Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, LXRX annual total long term liabilities has changed by +$50.77 M (+94.01%)
What is Lexicon Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of LXRX is $106.56 M
What is the all time high quarterly long term liabilities for Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals all-time high quarterly total long term liabilities is $275.98 M
What is Lexicon Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, LXRX quarterly total long term liabilities has changed by +$1.86 M (+1.77%)